Chest
EditorialsPulmonary Hypertension: From an Orphan Disease to a Public Health Problem
References (12)
- et al.
Primary pulmonary hypertension
Lancet
(2003) - et al.
Risk factors for pulmonary arterial hypertension
Clin Chest Med
(2001) - et al.
Registry and survival in Chinese patients with idiopathic and familial pulmonary arterial hypertension
Chest
(2007) - et al.
Global alliance against chronic respiratory diseases
Allergy
(2007) - et al.
Clinical classification of pulmonary hypertension
J Am Coll Cardiol
(2004) - et al.
Pulmonary arterial hypertension in France: results from a national registry
Am J Respir Crit Care Med
(2006)
Cited by (0)
Dr. Humbert is Professor, Centre National de Référence sur l'Hypertension Artérielle Pulmonaire, Hôpital Antoine-Béclère, Université Paris-Sud, Assistance Publique - Hôpitaux de Paris. Dr. Khaltaev is Professor, World Health Organization. Dr. Bousquet is Professor, Clinique des Maladies Respiratoires, Hôpital Arnaud de Villeneuve, Université de Montpellier. Dr. Souza is Professor, Pulmonary Hypertension Unit, Pulmonary Department, University of Sao Paulo.
Drs. Humbert and Souza have relationships with drug companies including Actelion, Encysive, GlaxoSmithKline, Schering, Pfizer, and United Therapeutics. In addition to being investigators in trials involving these companies, relationships include consultancy services and membership of scientific advisory boards. Drs. Khaltaev and Bousquet have no conflicts of interest to disclose.